COX6B2 Antikörper (N-Term)
-
- Target Alle COX6B2 Antikörper anzeigen
- COX6B2 (Cytochrome C Oxidase Subunit VIb Polypeptide 2 (Testis) (COX6B2))
- Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser COX6B2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Spezifität
- COX6B2 Antibody detects endogenous levels of total COX6B2.
- Homologie
- Pig,Bovine
- Aufreinigung
- The antiserum was purified by peptide affinity chromatography using SulfoLinkTM Coupling Resin (Thermo Fisher Scientific).
- Immunogen
- A synthesized peptide derived from human COX6B2, corresponding to a region within N-terminal amino acids.
- Isotyp
- IgG
- Top Product
- Discover our top product COX6B2 Primärantikörper
-
-
- Applikationshinweise
- WB 1:1000-3000, IHC 1:200, ELISA(peptide) 1:20000-1:40000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C. Stable for 12 months from date of receipt.
- Haltbarkeit
- 12 months
-
- Target
- COX6B2 (Cytochrome C Oxidase Subunit VIb Polypeptide 2 (Testis) (COX6B2))
- Andere Bezeichnung
- COX6B2 (COX6B2 Produkte)
- Synonyme
- COXVIB2 antikoerper, CT59 antikoerper, 1700067P11Rik antikoerper, BC048670 antikoerper, cox6b2 antikoerper, MGC66195 antikoerper, cytochrome c oxidase subunit 6B2 antikoerper, cytochrome c oxidase subunit VIb polypeptide 2 antikoerper, COX6B2 antikoerper, Cox6b2 antikoerper, cox6b2 antikoerper
- Hintergrund
-
Description: Connects the two COX monomers into the physiological dimeric form.
Gene: COX6B2
- Molekulargewicht
- 11 kDa
- Gen-ID
- 125965
- UniProt
- Q6YFQ2
-